{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:30:37Z","timestamp":1790544637785,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ijbiomac.2017.05.179","type":"journal-article","created":{"date-parts":[[2017,6,4]],"date-time":"2017-06-04T00:16:32Z","timestamp":1496535392000},"page":"180-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"PA","title":["Nicotinic acetylcholine receptor alpha 1(nAChR\u03b11) subunit peptides as potential antiviral agents against rabies virus"],"prefix":"10.1016","volume":"104","author":[{"given":"Basavaraj","family":"Sajjanar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyani","family":"Dhusia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Bisht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimpal","family":"Thakuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gundallahalli B.","family":"Manjunathareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod W.","family":"Ramteke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0005","unstructured":"WHO Expert Consultation on Rabies, Second Report WHO technical report series; no. 982, (2013)."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/INF.0000000000000641","article-title":"The Milwaukee protocol for treatment of human ra-Rabies is no longer valid","volume":"34","author":"Wilde","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0015","doi-asserted-by":"crossref","first-page":"e0132160","DOI":"10.1371\/journal.pone.0132160","article-title":"Public health responses to reemergence of animal rabies","volume":"10","author":"Huang","year":"2015","journal-title":"Taiwan PLoS ONE"},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0020","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4161\/hv.3.5.4386","article-title":"Use of neutralizing murine monoclonal antibodies to rabies glycoprotein in passive immunotherapy against rabies","volume":"5","author":"Muhamuda","year":"2007","journal-title":"Hum. Vaccine"},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0025","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity","volume":"26","author":"Bakker","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0030","series-title":"Virus Taxonomy: Classification and Nomenclature of Viruses: Ninth Report of the International Committee on the Taxonomy of Viruses","author":"King","year":"2012"},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2005.04.004","article-title":"Replication strategies of rabies virus","volume":"111","author":"Finke","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0040","doi-asserted-by":"crossref","first-page":"8746","DOI":"10.1128\/JVI.78.16.8746-8752.2004","article-title":"Evidence that rabies virus forms different kinds of fusion machines with different pH thresholds for fusion","volume":"78","author":"Roche","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13550280590900427","article-title":"Rabies virus receptors","volume":"11","author":"Lafon","year":"2005","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0050","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1099\/0022-1317-77-10-2437","article-title":"Rabies virus binding to the nicotinic acetylcholine receptor (subunit demonstrated by the virus overlay protein binding assay","volume":"77","author":"Gustka","year":"1996","journal-title":"J. Gen.Virol."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0055","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1099\/0022-1317-71-4-751","article-title":"The recognition event between virus and host cell receptor: a target for antiviral agents","volume":"71","author":"Lentz","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0060","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/bip.360330612","article-title":"A model of the rabies virus glycoprotein active site","volume":"33","author":"Rustici","year":"1993","journal-title":"Biopolymers"},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2260","article-title":"The cell biology of rabiesvirus: using stealth to reach the brain","volume":"8","author":"Schnell","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0070","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0003-2697(70)90146-6","article-title":"Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides","volume":"34","author":"Kaiser","year":"1970","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0075","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0168-9525(00)02024-2","article-title":"EMBOSS the European molecular biology open software suite","volume":"16","author":"Rice","year":"2000","journal-title":"Trends Genet."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0080","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/nar\/gkg563","article-title":"ExPASy the proteomics server for in-depth protein knowledge and analysis","volume":"31","author":"Gasteiger","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0085","first-page":"310","article-title":"Prediction of glycosylation across the human proteome and the correlation to protein function","author":"Gupta","year":"2002","journal-title":"Pac. Symp. Biocomput."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0090","doi-asserted-by":"crossref","first-page":"14021406","DOI":"10.1110\/ps.03479604","article-title":"Predicting subcellular localization of proteins for gram-negative bacteria by support vector machines based on n-peptide compositions","volume":"13","author":"Yu","year":"2004","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK. a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl Cryst."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0100","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0076-6879(97)77022-8","article-title":"VERIFY3D: assessment of protein models with three-dimensional profiles","volume":"277","author":"Eisenberg","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0105","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0110","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/nar\/gki481","article-title":"PatchDock and SymmDock: servers for rigid and symmetric docking","volume":"33","author":"Schneidman-Duhovny","year":"2005","journal-title":"Nucl. Acids. Res."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0115","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pneurobio.2004.09.006","article-title":"Neuronal nicotinic receptors: from structure to pathology","volume":"74","author":"Gotti","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ijbiomac.2007.05.012","article-title":"Circular dichroism studies of extracellular domains of human nicotinic acetylcholine receptors provide an insight into their structure","volume":"41","author":"Zouridakis","year":"2007","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0130","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nn1942","article-title":"Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution","volume":"10","author":"Dellisanti","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0135","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijbiomac.2013.11.003","article-title":"Expression of human AChR extracellular domain mutants with improved characteristics","volume":"63","author":"Lazaridis","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0140","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4103\/0250-474X.73905","article-title":"Molecular docking studies with rabies virus glycoprotein to design viral therapeutics","volume":"72","author":"Tomar","year":"2010","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0145","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/molecules16010221","article-title":"Targeting cell entry of enveloped viruses as an antiviral strategy","volume":"16","author":"Teissier","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0150","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1128\/JVI.78.14.7410-7417.2004","article-title":"Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides","volume":"78","author":"Real","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0155","doi-asserted-by":"crossref","first-page":"10808","DOI":"10.1128\/JVI.00977-09","article-title":"Peptides that mimic the amino-terminal end of the rabies virus phosphoprotein have antiviral activity","volume":"83","author":"Castel","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2017.05.179_bib0160","doi-asserted-by":"crossref","first-page":"E861","DOI":"10.1073\/pnas.1210198110","article-title":"Host\u2013rabies virus protein\u2013protein interactions as druggable antiviral targets","volume":"110","author":"Lingappa","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813017312643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813017312643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T15:17:51Z","timestamp":1575645471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813017312643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":32,"alternative-id":["S0141813017312643"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.05.179","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotinic acetylcholine receptor alpha 1(nAChR\u03b11) subunit peptides as potential antiviral agents against rabies virus","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.05.179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}